Cardiol Therapeutics Inc (CRDL)

Apr 21, 2025

Genocea Biosciences (NASDAQ:GNCA) versus Cardiol Therapeutics (NASDAQ:CRDL) Head-To-Head Review - Defense World

Apr 21, 2025

Apr 19, 2025

(CRDL) Investment Analysis and Advice (CRDL:CA) - news.stocktradersdaily.com

Apr 19, 2025

Apr 19, 2025

Roth Capital Has Bearish Forecast for CRDL Q1 Earnings - Defense World

Apr 19, 2025

Apr 19, 2025

Cardiol Therapeutics (CRDL) Projected to Post Quarterly Earnings on Monday - Defense World

Apr 19, 2025

Apr 18, 2025

Cardiol Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

Apr 18, 2025

Apr 18, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Earns “Buy” Rating from HC Wainwright - Defense World

Apr 18, 2025

Apr 17, 2025

Northwestern University enrols first subject in trial of drug for pericarditis - Yahoo

Apr 17, 2025

Apr 16, 2025

(CRDL) Pivots Trading Plans and Risk Controls (CRDL:CA) - news.stocktradersdaily.com

Apr 16, 2025

Apr 16, 2025

ardiol Therapeutics Inc. - Baystreet.ca

Apr 16, 2025

Apr 16, 2025

Cardiol Therapeutics Commences Phase III Trial for CardiolRx™ in Recurrent Pericarditis - TipRanks

Apr 16, 2025

Apr 16, 2025

Cardiol Therapeutics starts phase III trial for heart drug - Investing.com Australia

Apr 16, 2025

Apr 16, 2025

Breakthrough Pericarditis Drug Enters Pivotal Phase III Trial After Phase II Success - Stock Titan

Apr 16, 2025

Apr 16, 2025

3 Reasons to Sell CSV and 1 Stock to Buy Instead - The Globe and Mail

Apr 16, 2025

Apr 16, 2025

Analysts Set Cardiol Therapeutics Inc. (NASDAQ:CRDL) Price Target at $8.40 - Defense World

Apr 16, 2025

Apr 14, 2025

Cardiol Therapeutics Reports Increased Losses Amid Rising Expenses - TipRanks

Apr 14, 2025

Apr 11, 2025

Long Term Trading Analysis for (CRDL) (CRDL:CA) - news.stocktradersdaily.com

Apr 11, 2025

Apr 11, 2025

HC Wainwright Has Negative Outlook for CRDL FY2025 Earnings - Defense World

Apr 11, 2025

Apr 08, 2025

H.C. Wainwright maintains $9 target on Cardiol Therapeutics stock By Investing.com - Investing.com UK

Apr 08, 2025

Apr 08, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Receives “Buy” Rating from HC Wainwright - Defense World

Apr 08, 2025

Apr 08, 2025

Cardiol Therapeutics (TSE:CRDL) Reaches New 1-Year Low – Should You Sell? - Defense World

Apr 08, 2025

Apr 02, 2025

Cardiol Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 02, 2025

Apr 02, 2025

We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate - Yahoo Finance

Apr 02, 2025

Apr 01, 2025

Cardiol Therapeutics advances heart disease treatments By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Cardiol Therapeutics Inc. - menafn

Apr 01, 2025

Apr 01, 2025

Stocks In Play: Cardiol Therapeutics Inc. - Barchart.com

Apr 01, 2025

Apr 01, 2025

Cardiol Therapeutics Advances Heart Disease Treatments with Promising Clinical Results - TipRanks

Apr 01, 2025

Apr 01, 2025

Cardiol Therapeutics advances heart disease treatments - Investing.com

Apr 01, 2025

Apr 01, 2025

Cardiol Therapeutics Announces Year-End 2024 Update on Operations - Newsfile

Apr 01, 2025

Apr 01, 2025

Virtu Financial LLC Invests $61,000 in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World

Apr 01, 2025

Mar 28, 2025

Cardiol Therapeutics Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView

Mar 28, 2025

Mar 26, 2025

Cardiol Therapeutics (TSE:CRDL) Stock Price Down 5% – Time to Sell? - Defense World

Mar 26, 2025

Mar 20, 2025

Atria Investments Inc Takes Position in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World

Mar 20, 2025

Mar 14, 2025

Cardiol Therapeutics Schedules Annual General Meeting for May 2025 - TipRanks

Mar 14, 2025

Mar 06, 2025

Financial Comparison: Cardiol Therapeutics (NASDAQ:CRDL) versus Cortexyme (NASDAQ:CRTX) - Defense World

Mar 06, 2025

Mar 03, 2025

Cardiol Therapeutics to Present at TD Cowen Health Care Conference - TipRanks

Mar 03, 2025

Mar 03, 2025

Cardiol Therapeutics to present at health care conference - Proactive Investors USA

Mar 03, 2025

Mar 03, 2025

Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference - Newsfile

Mar 03, 2025

Mar 03, 2025

Can Cardiol's Presentation at Major Healthcare Conference Signal New Clinical Developments? - Stock Titan

Mar 03, 2025

Feb 27, 2025

Cardiol Therapeutics (TSE:CRDL) Hits New 12-Month LowWhat's Next? - MarketBeat

Feb 27, 2025

Feb 26, 2025

Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302 - Investing News Network

Feb 26, 2025

Feb 26, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Receives Buy Rating from HC Wainwright - MarketBeat

Feb 26, 2025

Feb 25, 2025

Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives $8.40 Average PT from Analysts - Defense World

Feb 25, 2025

Feb 25, 2025

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Fa - Newsfile

Feb 25, 2025

Feb 24, 2025

Promising Potential of Cardiol Therapeutics’ CRD-38 Justifies Buy Rating Amidst Market Need for HFpEF Treatment - TipRanks

Feb 24, 2025

Feb 21, 2025

JACC data highlights Cardiol’s potential to differentiate in HF space - Yahoo Finance

Feb 21, 2025

Feb 20, 2025

Cardiol Therapeutics reports heart failure treatment progress By Investing.com - Investing.com Nigeria

Feb 20, 2025

Feb 20, 2025

Cardiol Therapeutics says study shows benefit of cannabidiol drug in treating heart failure - Proactive financial news

Feb 20, 2025